瑞加诺生负荷心肌灌注显像中缺血性心电图改变的预后意义
本研究为回顾性队列研究,纳入8615例接受瑞加诺生负荷SPECT心肌灌注显像的患者,评估缺血性ST段压低(ST↓)的预后价值及最佳阈值。结果显示ST↓≥0.5 mm与主要不良心脏事件(MACE)独立相关(HR 2.14),且增量预后价值优于≥1.0 mm阈值;瑞加诺生诱发的ST↓在女性中更常见。
要点
- 瑞加诺生诱发缺血性ST↓在女性中更常见(P < .001)。
- ST↓≥0.5 mm与MACE独立相关(HR 2.14;CI 1.38-3.32;P = .001)。
- ST↓≥0.5 mm阈值较≥1.0 mm提供更大的增量预后价值(Δχ2 = 12.78 vs 3.72)。
核心结论
- 瑞加诺生诱发的缺血性ST↓在女性中更常见,且在心肌灌注显像和临床参数之外提供适度的独立预后价值。
- ST↓≥0.5 mm是比≥1.0 mm更好的阈值,用于定义瑞加诺生诱发心肌缺血的心电图证据。
研究设计与样本
- 回顾性队列研究,连续纳入转诊接受瑞加诺生负荷SPECT心肌灌注显像的患者,排除心电图无法判读者。
- 共纳入8615例受试者(平均年龄62 ± 13岁;55%为女性)。
- 研究了两个诊断阈值:水平型或下斜型ST↓≥0.5 mm和≥1.0 mm。
- 主要终点为主要不良心脏事件(MACE)复合终点,包括心源性死亡、心肌梗死或冠状动脉血运重建。
- 平均随访2.5 ± 2.2年。
主要发现
- 89例(1.0%)有ST↓≥1.0 mm,133例(1.5%)有ST↓≥0.5 mm。
- 瑞加诺生诱发的ST↓在女性中更常见(P < .001)。
- 多变量调整后,ST↓≥1.0 mm与MACE风险增加无显著关联(P = .069),无论MPI异常(P = .162)或正常(P = .214)。
- ST↓≥0.5 mm在全队列中与MACE独立相关(HR 2.14;CI 1.38-3.32;P = .001),MPI正常时(HR 2.07;CI 1.07-4.04;P = .032)或异常时(HR 2.24;CI 1.23-4.00;P = .007)均独立相关,已调整临床和影像协变量。
- ST↓≥0.5 mm阈值在临床和影像参数之外的增量预后价值(Δχ2 = 12.78;P < .001)大于≥1.0 mm阈值(Δχ2 = 3.72;P = .093)。
关键数值与推荐
- ST↓≥0.5 mm定义瑞加诺生诱发心肌缺血的心电图证据优于≥1.0 mm阈值。
- ST↓≥0.5 mm与MACE独立相关(HR 2.14;CI 1.38-3.32;P = .001)。
- ST↓≥1.0 mm与MACE风险增加无显著关联(P = .069)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients undergoing regadenoson SPECT myocardial perfusion imaging (MPI), the prognostic value of ischemic ST-segment depression (ST↓) and the optimal ST↓ threshold have not been studied. METHODS: A retrospective cohort study of consecutive patients referred for regadenoson stress MPI was conducted. Patients with uninterpretable ECG were excluded. Two diagnostic thresholds of horizontal or downsloping ST↓ were studied, ≥ 0.5 mm and ≥ 1.0 mm. The primary endpoint was the composite major adverse cardiac events (MACE) of cardiac death, myocardial infarction, or coronary revascularization. RESULTS: Among 8615 subjects (mean age 62 ± 13 years; 55% women), 89 (1.0%) had ST↓ ≥ 1.0 mm and 133 (1.5%) had ST↓ ≥ 0.5 mm. Regadenoson-induced ST↓ was more common in women (P < .001). Mean follow-up was 2.5 ± 2.2 years. After multivariate adjustment, ST↓ ≥ 1.0 mm was associated with a non-significant increase in MACE risk (P = .069), irrespective to whether MPI was abnormal (P = .162) or normal (P = .214). Ischemic ST↓ ≥ 0.5 mm was independently associated with MACE in the entire cohort (HR 2.14; CI 1.38-3.32; P = .001), whether MPI is normal (HR 2.07; CI 1.07-4.04; P = .032) or abnormal (HR 2.24; CI 1.23-4.00; P = .007), after adjusting for clinical and imaging covariates. An ST↓ threshold of ≥ 0.5 mm provided greater incremental prognostic value beyond clinical and imaging parameters (Δχ2 = 12.78; P < .001) than ≥ 1.0 mm threshold (Δχ2 = 3.72; P = .093). CONCLUSION: Regadenoson-induced ischemic ST↓ is more common in women and it provides a modest independent prognostic value beyond MPI and clinical parameters. ST↓ ≥ 0.5 mm is a better threshold than ≥ 1.0 mm to define ECG evidence for regadenoson-induced myocardial ischemia.
引用
- Doukky R, Nigatu A, Khan R, et al. Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging. J Nucl Cardiol. 2018. PMID: 30132187. doi:10.1007/s12350-018-1415-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。